ACCC Clears $68B Pfizer, Wyeth Deal With Conditions
Pfizer Inc. has obtained the Australian Competition and Consumer Commission's approval for its $68 billion acquisition of rival drugmaker Wyeth Inc., subject to the divestiture of certain Australian animal health assets....To view the full article, register now.
Already a subscriber? Click here to view full article